Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Barbara Bellar

Family Medicine Oakbrook Terrace, IL Medical Doctor

NPI 1447309208 CMS profile 831432

1116 Oxford Ct, Oakbrook Terrace, IL 60181

Open in the dashboard

General payments

$598,593

558 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Barbara Bellar of Oakbrook Terrace, IL is reported in the CMS Open Payments database as having received $598,593 across 558 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $163,638 201
2024 General $177,261 135
2023 General $120,314 88
2022 General $42,315 39
2021 General $26,405 25
2020 General $34,071 30
2019 General $34,590 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Barbara Bellar
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Barbara Bellar were reported at $163,638. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Barbara Bellar Family Medicine median Middle half National median
2019 $34,590 $150 $41–$543 $163
2020 $34,071 $120 $32–$415 $114
2021 $26,405 $137 $35–$551 $132
2022 $42,315 $137 $37–$512 $149
2023 $120,314 $149 $42–$545 $160
2024 $177,261 $156 $44–$560 $164
2025 $163,638 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CSL Plasma Inc. $461,213 424 payments
  2. CSL Behring $125,571 122 payments
  3. Shire North American Group Inc $5,800 3 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $5,800 3 payments
  5. GlaxoSmithKline, LLC. $141 2 payments
  6. Novo Nordisk Inc $21 1 payment
  7. Janssen Pharmaceuticals, Inc $18 1 payment
  8. Amgen Inc. $15 1 payment
  9. Lilly USA, LLC $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $598,384 552 payments
  2. Food and Beverage $209 6 payments
Products named General payments · program years 2019–2025
  1. BEXSERO $141 2 payments
  2. Tresiba $21 1 payment
  3. XARELTO $18 1 payment
  4. MENVEO $18 1 payment
  5. PEDIARIX $18 1 payment
  6. EVENITY $15 1 payment
  7. Prolia $15 1 payment
  8. TRULICITY $14 1 payment
  9. JARDIANCE $14 1 payment
  10. BASAGLAR $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

265

Median for Family Practice: 1,826

Drug cost

$7,328

Median for Family Practice: $120,094

Branded share of claims

8.3%

Median for Family Practice: 18.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 22 $5,186
Sertraline Hcl Generic 24 $288
Omeprazole Generic 27 $278
Amlodipine Besylate Generic 34 $260
Gabapentin Generic 27 $221
Atorvastatin Calcium Generic 24 $203
Escitalopram Oxalate Generic 14 $153
Levothyroxine Sodium Generic 19 $149
Potassium Chloride Generic 18 $146
Finasteride Generic 13 $140

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$94,878

Medicare's payments for the services billed

Medicare patients

538

Average age 75

Services billed

1,360

371 women, 167 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Diabetes 46%
Depression 43%
Ischemic heart disease 36%
Chronic kidney disease 33%
Heart failure 27%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

558 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record